546 related articles for article (PubMed ID: 28615039)
1. Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.
Tormo A; Khodayarian F; Cui Y; Al-Chami E; Kanjarawi R; Noé B; Wang H; Rafei M
J Hematol Oncol; 2017 Jun; 10(1):120. PubMed ID: 28615039
[TBL] [Abstract][Full Text] [Related]
2. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.
Alpdogan O; Schmaltz C; Muriglan SJ; Kappel BJ; Perales MA; Rotolo JA; Halm JA; Rich BE; van den Brink MR
Blood; 2001 Oct; 98(7):2256-65. PubMed ID: 11568014
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7.
Bolotin E; Smogorzewska M; Smith S; Widmer M; Weinberg K
Blood; 1996 Sep; 88(5):1887-94. PubMed ID: 8781449
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. Donor T-cell-derived interleukin-22 promotes thymus regeneration and alleviates chronic graft-versus-host disease in murine allogeneic hematopoietic cell transplant.
Pan B; Zhang F; Lu Z; Li L; Shang L; Xia F; Fu R; Xu M; Zeng L; Xu K
Int Immunopharmacol; 2019 Feb; 67():194-201. PubMed ID: 30557822
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants.
Broers AE; Posthumus-van Sluijs SJ; Spits H; van der Holt B; Löwenberg B; Braakman E; Cornelissen JJ
Blood; 2003 Aug; 102(4):1534-40. PubMed ID: 12714515
[TBL] [Abstract][Full Text] [Related]
7. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
8. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
9. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
10. [The role of IL-22 on thymus recovery and its function in mice following allogeneic bone marrow transplantation].
Zhao K; Zhao D; Yin L; Pan B; Xu K
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):822-5. PubMed ID: 25246251
[TBL] [Abstract][Full Text] [Related]
11. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
[TBL] [Abstract][Full Text] [Related]
12. Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model.
Ito M; Shizuru JA
Biol Blood Marrow Transplant; 1999; 5(6):357-68. PubMed ID: 10595813
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure.
Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U
Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation.
Goldberg GL; Alpdogan O; Muriglan SJ; Hammett MV; Milton MK; Eng JM; Hubbard VM; Kochman A; Willis LM; Greenberg AS; Tjoe KH; Sutherland JS; Chidgey A; van den Brink MR; Boyd RL
J Immunol; 2007 Jun; 178(11):7473-84. PubMed ID: 17513799
[TBL] [Abstract][Full Text] [Related]
15. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.
Dudakov JA; Mertelsmann AM; O'Connor MH; Jenq RR; Velardi E; Young LF; Smith OM; Boyd RL; van den Brink MRM; Hanash AM
Blood; 2017 Aug; 130(7):933-942. PubMed ID: 28607133
[TBL] [Abstract][Full Text] [Related]
16. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.
Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S
Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299
[TBL] [Abstract][Full Text] [Related]
17. Co‑transplantation of tonsil‑derived mesenchymal stromal cells in bone marrow transplantation promotes thymus regeneration and T cell diversity following cytotoxic conditioning.
Choi DW; Cho KA; Lee HJ; Kim YH; Woo KJ; Park JW; Ryu KH; Woo SY
Int J Mol Med; 2020 Sep; 46(3):1166-1174. PubMed ID: 32582998
[TBL] [Abstract][Full Text] [Related]
18. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation.
Mackall CL; Fry TJ; Bare C; Morgan P; Galbraith A; Gress RE
Blood; 2001 Mar; 97(5):1491-7. PubMed ID: 11222398
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
Zhang Y; Hexner E; Frank D; Emerson SG
J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
[TBL] [Abstract][Full Text] [Related]
20. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
